These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3714732)

  • 21. Comparison of metastasis of mammary tumors growing in the mammary fatpad versus the subcutis.
    Miller FR
    Invasion Metastasis; 1981; 1(4):220-6. PubMed ID: 7188387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
    Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
    Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomes as drug carriers in cancer therapy: hyperthermia and pH sensitivity as modalities for targeting.
    Yatvin MB; Cree TC; Tegmo-Larsson IM; Gipp JJ
    Strahlentherapie; 1984 Dec; 160(12):732-40. PubMed ID: 6393456
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms].
    Ramanauskaĭte RIu; Abronina IF; Karaseva LI; Sergeev AV
    Biull Eksp Biol Med; 1994 Sep; 118(9):295-7. PubMed ID: 7819566
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of tumor metastasis by a circulating suppressor factor.
    Torosian MH; Bartlett DL
    J Surg Res; 1993 Jul; 55(1):74-9. PubMed ID: 8412085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis.
    Lagarde AE; Donaghue TP; Dennis JW; Kerbel RS
    J Natl Cancer Inst; 1983 Jul; 71(1):183-91. PubMed ID: 6575202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Growth behavior of human neoplasms following transplantation into nu/nu mice. I. Dependency on the age of recipient animals].
    Bader A; Fortmeyer HP; Lapp C; Bastert G
    Z Versuchstierkd; 1981; 23(3):161-8. PubMed ID: 7314994
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mts1 protein and control of tumor metastasis].
    Georgiev GP; Lukanidin EM
    Mol Biol (Mosk); 2000; 34(5):727-30. PubMed ID: 11033794
    [No Abstract]   [Full Text] [Related]  

  • 29. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
    Griswold DP
    Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages.
    Okuno K; Hashimoto T; Qian JH; Tsuchida T; Fujiwara H; Hamaoka T
    Jpn J Clin Oncol; 1985 Mar; 15(1):87-94. PubMed ID: 3981817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mouse models of mammary tumorigenesis.
    Cardiff RD; Muller WJ
    Cancer Surv; 1993; 16():97-113. PubMed ID: 8394206
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L; Maddock CL; Hall TC
    J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor heterogeneity, invasion and metastasis. June 3-5, 1981, Saskatoon, Sask., Canada.
    Kerbel RS
    Invasion Metastasis; 1982; 2(1):61-75. PubMed ID: 7188392
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental studies of tumor metastasis and the drug sensitivity.
    Tsukagoshi S
    Prog Clin Biol Res; 1986; 223():95-102. PubMed ID: 3809202
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors.
    Loveless SE; Heppner GH
    J Immunol; 1983 Oct; 131(4):2074-8. PubMed ID: 6619548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of drug resistance markers to recover clonogenic tumor cells from occult metastases in host tissues.
    Miller FR; McInerney DJ; Rogers C; Aitken DR; Wei WZ
    Invasion Metastasis; 1986; 6(4):197-208. PubMed ID: 3759360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site.
    Shekhar PV; Werdell J; Christman JK; Miller FR
    Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the immunogenicity of tumor cells and the pattern of metastasis.
    Kim U
    Symp Fundam Cancer Res; 1983; 36():337-52. PubMed ID: 6382512
    [No Abstract]   [Full Text] [Related]  

  • 39. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.
    Rozanov DV; Savinov AY; Golubkov VS; Tomlinson S; Strongin AY
    Cancer Res; 2006 Jun; 66(12):6258-63. PubMed ID: 16778201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.